"Clinical and Treatment Characteristics of Patients Treated with the First Therapeutic Oncology Biosimilars Bevacizumab-awwb and Trastuzumab-anns in the US" by Reshma Mahtani

Article

Clinical and Treatment Characteristics of Patients Treated with the First Therapeutic Oncology Biosimilars Bevacizumab-awwb and Trastuzumab-anns in the US

Therapeutic Advances in Medical Oncology (2021)

Reshma Mahtani, Baptist Health South Florida

Link

Disciplines

Medicine and Health Sciences

Publication Date

September 1, 2021

Citation Information

Reshma Mahtani. "Clinical and Treatment Characteristics of Patients Treated with the First Therapeutic Oncology Biosimilars Bevacizumab-awwb and Trastuzumab-anns in the US" Therapeutic Advances in Medical Oncology (2021)
Available at: http://works.bepress.com/reshma-mahtani/101/